Evidence map›Paper›PMID 22423616›Full record

ArticleVascular cell2012

Pleiotrophin expression and role in physiological angiogenesis in vivo: potential involvement of nucleolin.

Marina Koutsioumpa, Georgia Drosou, Constantinos Mikelis, Katerina Theochari, Dionussios Vourtsis, Panagiotis Katsoris, Efstathia Giannopoulou, Jose Courty, Christos Petrou, Vassiliki Magafa and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Vascular cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Moesin is an αCellular and molecular life sciences : CMLS · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Marina Koutsioumpa *Laboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras GR 26504, Greece.
Georgia Drosou *Laboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras GR 26504, Greece.
Constantinos MikelisLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras GR 26504, Greece.
Katerina TheochariLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras GR 26504, Greece.
Dionussios VourtsisLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras GR 26504, Greece.
Panagiotis KatsorisDivision of Genetics, Cell & Developmental Biology, Department of Biology, University of Patras, Patras, Greece.
Efstathia GiannopoulouLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras GR 26504, Greece.
Jose CourtyLaboratoire CRRET, Université Paris Est Créteil, Val de Marne, 61 avenue du Général de Gaulle, 94010 Créteil, Cedex, France.
Christos PetrouLaboratory of Pharmacognocy and Chemistry of Natural Products, Department of Pharmacy, University of Patras, Athens, Greece.
Vassiliki MagafaLaboratory of Pharmacognocy and Chemistry of Natural Products, Department of Pharmacy, University of Patras, Athens, Greece.
Paul CordopatisLaboratory of Pharmacognocy and Chemistry of Natural Products, Department of Pharmacy, University of Patras, Athens, Greece.
Evangelia PapadimitriouLaboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras GR 26504, Greece.
University of Patras · GRGeneral University Hospital of Patras · GRNational Institutes of Health · USUniversité Paris-Est Créteil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPleiotrophin (PTN) is a heparin-binding growth factor with significant role(s) in tumour growth and angiogenesis. Although implication of endogenous PTN has been studied in several in vivo models of tumour angiogenesis, its role in physiological angiogenesis has not been addressed. In the present work, we studied expression and functional significance of endogenous PTN during angiogenesis in the chicken embryo chorioallantoic membrane (CAM).

methodsUsing molecular, cellular and biochemical assays, we studied the expression pattern of PTN in CAM and human endothelial cells and its possible interaction with nucleolin (NCL). CAM cells were transfected with a pCDNA3.1 vector, empty (PC) or containing full length cDNA for PTN in antisense orientation (AS-PTN). Angiogenesis was estimated by measuring total vessel length. In vitro, human endothelial cells migration was studied by using a transwell assay, and down-regulation of NCL was performed by using a proper siRNA.

resultsEndogenous PTN mRNA and protein levels, as well as protein levels of its receptor protein tyrosine phosphatase beta/zeta (RPTPβ/ζ) were maximal at early stages, when CAM angiogenesis is active. Application of AS-PTN onto CAM at days of active angiogenesis was not toxic to the tissue and led to dose-dependent decreased expression of endogenous PTN, ERK1/2 activity and angiogenesis. Interestingly, endogenous PTN was also immunolocalized at the endothelial cell nucleus, possibly through interaction with NCL, a protein that has a significant role in the nuclear translocation of many proteins. Down-regulation of NCL by siRNA in human endothelial cells significantly decreased nuclear PTN, verifying this hypothesis. Moreover, it led to abolishment of PTN-induced endothelial cell migration, suggesting, for the first time, that PTN-NCL interaction has a functional significance.

conclusionsExpression of endogenous PTN correlates with and seems to be involved in angiogenesis of the chicken embryo CAM. Our data suggest that NCL may have a role, increasing the number of growth factors whose angiogenic/tumorigenic activities are mediated by NCL.

Identifiers

PMID22423616
PMCPMC3379939
OpenAlexW2101852072

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.